T

Tetraphase

17 employees

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biopharma
multidrug-resistant infections
antibiotic resistance
Gram-negative antibiotics
Antibiotics
biopharmaceutical
Health Care
bacterial resistance

Date founded

2006

Funding rounds raised

Total raised

$45M

from 18 investors over 18 rounds

T

Tetraphase raised $4M on April 1, 2017

Investors: CARB-X

T

Tetraphase raised $45M on June 1, 2010

Investors: Mediphase Venture Partners, F-Prime Capital Partners, Sky Ventures, Flagship Ventures and Excel Venture Management, LLC

T

Tetraphase raised $25M on September 22, 2009

Investors: Mediphase Venture Partners, Sky Ventures, Flagship Ventures and F-Prime Capital Partners

T

Tetraphase raised $15M on August 7, 2008

Investors: CMEA Capital, Fidelity Growth Partners, Mediphase Venture Partners and Sky Ventures

T

Tetraphase raised $10M on November 1, 2006

Investors: Mediphase Venture Partners, Sky Ventures, F-Prime Capital Partners and Flagship Ventures

FAQ